Journal article
Combination of Whole Genome Sequencing, Linkage and Functional Studies Implicates a Missense Mutation in Titin as a Cause of Autosomal Dominant Cardiomyopathy with Features of Left Ventricular Non-Compaction.
- Abstract:
-
Background—High throughput next generation sequencing techniques have made whole genome sequencing accessible in clinical practice, however, the abundance of variation in the human genomes makes the identification of a disease-causing mutation on a background of benign rare variants challenging.
Methods and Results—Here we combine whole genome sequencing with linkage analysis in a three-generation family affected by cardiomyopathy with features of autosomal dominant left-ventricular non-compaction cardiomyopathy. A missense mutation in the giant protein titin is the only plausible disease-causing variant that segregates with disease amongst the eight surviving affected individuals, with interrogation of the entire genome excluding other potential causes. This A178D missense mutation, affecting a conserved residue in the second immunoglobulin-like domain of titin, was introduced in a bacterially expressed recombinant protein fragment and biophysically characterised in comparison to its wild-type counterpart. Multiple experiments, including size exclusion chromatography, small angle X-ray scattering and circular dichroism spectroscopy suggest partial unfolding and domain destabilisation in the presence of the mutation. Moreover, binding experiments in mammalian cells show that the mutation markedly impairs binding to the titin ligand telethonin.
Conclusions—Here we present genetic and functional evidence implicating the novel A178D missense mutation in titin as the cause of a highly penetrant familial cardiomyopathy with features of left-ventricular non-compaction. This expands the spectrum of titin's roles in cardiomyopathies. It furthermore highlights that rare titin missense variants, currently often ignored or left un-interpreted, should be considered to be relevant for cardiomyopathies and can be identified by the approach presented here.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, pdf, 9.2MB, Terms of use)
-
- Publisher copy:
- 10.1161/CIRCGENETICS.116.001431
Authors
+ British Heart Foundation
More from this funder
- Grant:
- FS/12/40/29712
- PG/15/113/31944
- HSRNWBY
- RE/13/1/30181
- HSRNWB11
- Publisher:
- Lippincott, Williams and Wilkins
- Journal:
- Circulation: Cardiovascular Genetics More from this journal
- Publication date:
- 2016-09-13
- Acceptance date:
- 2016-08-31
- DOI:
- EISSN:
-
1942-3268
- ISSN:
-
1942-325X, 1942-3268
- Keywords:
- Pubs id:
-
pubs:644383
- UUID:
-
uuid:66457dbe-346b-42bb-b80f-49accff1937e
- Local pid:
-
pubs:644383
- Deposit date:
-
2016-09-20
- ARK identifier:
Terms of use
- Copyright holder:
- Gehmlich et al
- Copyright date:
- 2016
- Notes:
- © 2016 The Authors. Circulation: Cardiovascular Genetics is published on behalf of the American Heart Association, Inc., by Wolters Kluwer. This is an open access article under the terms of the Creative Commons Attribution License.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record